Novo Nordisk, the maker of Wegovy, plans a major restructuring. The company will cut 9,000 jobs globally. This move aims to save 8 billion Danish crowns annually. The restructuring will simplify the organisation. It will also speed up decision-making. Novo Nordisk faces increasing competition from Eli Lilly.
​Novo Nordisk, the maker of Wegovy, plans a major restructuring. The company will cut 9,000 jobs globally. This move aims to save 8 billion Danish crowns annually. The restructuring will simplify the organisation. It will also speed up decision-making. Novo Nordisk faces increasing competition from Eli Lilly. by Soban News (international And National News)
